Eli Lilly plans $3.5 billion manufacturing plant in Pennsylvania to make next-generation obesity injections by CNBC Markets | January 30, 2026 10:19 pm | US Markets The plant will help make Lilly’s experimental drug called retatrutide, which has shown the highest weight loss seen to date in a late-stage trial.
